Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

Average Weight Loss On Mounjaro: By Month

See the average weight loss on Mounjaro broken down by month. Understand the dose titration timeline, what each month looks like, and how to optimize your monthly progress.

Reviewed by Form Blends Medical Team|Updated March 2026

Average Weight Loss On Mounjaro: By Month

Mounjaro (tirzepatide) delivers some of the fastest and most substantial monthly weight loss of any GLP-1 medication, with patients losing an average of 4 to 6 pounds per month during the first 6 months and continuing to lose weight through at least 18 months of treatment. Here is exactly what the data shows for each month.

Mounjaro's dual GIP/GLP-1 receptor mechanism produces consistently higher monthly weight loss rates compared to single-receptor GLP-1 medications. Understanding the month-by-month trajectory helps you evaluate your own progress and work with your provider to optimize results. how Mounjaro works

Month-by-Month Weight Loss Data

The following table synthesizes data from the SURMOUNT-1 trial (patients with obesity, no diabetes) across all three dose levels. Starting weight in the trial was approximately 231 pounds on average.

Average Monthly Weight Loss on Mounjaro by Dose
Month Dose Range Cumulative Loss (5 mg) Cumulative Loss (10 mg) Cumulative Loss (15 mg)
1 2.5 mg 3 to 4 lbs 3 to 5 lbs 4 to 6 lbs
2 5 mg 8 to 10 lbs 9 to 11 lbs 10 to 13 lbs
3 5 to 7.5 mg 13 to 15 lbs 15 to 18 lbs 17 to 20 lbs
4 7.5 to 10 mg 16 to 19 lbs 20 to 24 lbs 23 to 27 lbs
6 10 to 15 mg 22 to 25 lbs 28 to 33 lbs 33 to 38 lbs
9 Maintenance 27 to 30 lbs 36 to 40 lbs 40 to 44 lbs
12 Maintenance 30 to 33 lbs 40 to 43 lbs 44 to 47 lbs
18 (end SURMOUNT-1) Maintenance ~35 lbs ~45 lbs ~48 lbs

What Each Month Looks Like in Practice

Month 1: Getting Started (2.5 mg)

The 2.5 mg introductory dose lets your body adjust to tirzepatide's effects. Even at this low dose, most patients experience a noticeable shift in appetite. Meals become more manageable, and between-meal hunger decreases. Weight loss during this first month typically ranges from 3 to 6 pounds.

Side effects are generally mild. The most common are nausea (affecting about 15% to 20% of patients), decreased appetite, and occasional diarrhea or constipation. These symptoms usually peak during the first week and improve as your body adapts. Mounjaro first month tips

Month 2: Noticeable Appetite Changes (5 mg)

The step up to 5 mg brings stronger appetite suppression. Many patients say this is the month where they truly feel the medication working. Portions shrink naturally, and the urge to snack or eat out of boredom diminishes. Cumulative weight loss reaches roughly 4% to 5% of starting weight.

This is also when patients begin to notice subtle changes in how their clothes fit. The scale may show 8 to 13 pounds lost, depending on the target dose. Blood sugar levels often start improving during this month, particularly for patients with insulin resistance or prediabetes.

Month 3: Visible Progress (7.5 mg)

By month 3, many patients have lost enough weight for the changes to become visible. Faces appear slimmer, waistlines shrink, and rings and watches may feel looser. Cumulative weight loss often reaches 7% to 9% of starting weight on the higher dose tracks.

Energy and mobility improvements are common during this month. Patients who were previously limited in their physical activity often find they can walk farther, climb stairs more easily, and exercise with less discomfort. This creates a positive feedback loop that supports ongoing weight loss. exercise on Mounjaro

Months 4 to 6: Peak Rate Phase (10 to 15 mg)

This period typically produces the fastest monthly weight loss rates. Patients are reaching or have reached their target maintenance dose, and the dual GIP/GLP-1 mechanism is operating at full strength. Monthly losses of 3 to 5 pounds are common during this stretch.

By month 6, cumulative weight loss often reaches 14% to 17% of starting weight on the 15 mg dose. To put that in practical terms, a patient who started at 250 pounds is now around 210 to 215 pounds. That is a substantial visible transformation.

Health markers frequently improve dramatically during this phase. Blood pressure, triglycerides, HbA1c, liver enzymes, and inflammatory markers often show significant positive changes. Many patients are able to reduce or eliminate other medications under their provider's guidance. Mounjaro metabolic improvements

Months 7 to 12: Continued Progress

The rate of monthly weight loss gradually decreases during this period, but weight continues to come off. Monthly losses of 1 to 3 pounds are typical. This deceleration is biologically normal as the body adjusts to a lower weight and the caloric deficit narrows.

By month 12, patients on the 15 mg dose have typically lost 19% to 21% of their starting weight. The 10 mg dose group reaches approximately 17% to 19%, and the 5 mg group reaches approximately 13% to 15%. All three dose levels produce clinically meaningful results.

Months 13 to 18: Extended Results

The SURMOUNT-1 trial ran through 72 weeks (approximately 18 months), and weight loss continued throughout. The final 6 months of the trial added approximately 1% to 2% more weight loss for most patients. While the monthly rate is modest during this phase, the fact that weight continues trending downward rather than rebounding is significant.

How Mounjaro Monthly Weight Loss Compares

Monthly Weight Loss Rate Comparison (Approximate)
Medication Avg Monthly Loss (Months 2-6) Avg Monthly Loss (Months 7-12) Total at 12 Months
Mounjaro 15 mg 4 to 6 lbs 1 to 3 lbs 44 to 47 lbs
Wegovy 2.4 mg 3 to 5 lbs 1 to 2 lbs 33 to 35 lbs
Ozempic 1.0 mg 2 to 4 lbs 1 to 2 lbs 20 to 28 lbs

Mounjaro vs Wegovy vs Ozempic

Maximizing Each Month

Protein at every meal. As your total caloric intake drops, making sure protein makes up a larger share of your diet helps preserve muscle mass and keeps you feeling satisfied between meals. Aim for 80 to 120 grams daily. nutrition guide for Mounjaro patients

Stay hydrated. Dehydration is one of the most under-recognized issues for patients on GLP-1 medications. When you eat less, you also consume less water from food. Aim for at least 64 to 80 ounces of fluids daily.

Build exercise gradually. Start where you are comfortable and add intensity over time. Walking is an excellent foundation. As your weight decreases and your energy improves, consider adding swimming, cycling, or resistance training to further enhance your results.

Manage expectations during plateaus. Nearly every patient experiences at least one plateau during their Mounjaro treatment. A plateau lasting 2 to 4 weeks is normal. If it extends beyond 6 weeks, work with your provider to explore potential adjustments.

Frequently Asked Questions

How much weight will I lose in the first 3 months on Mounjaro?

Most patients lose 7% to 9% of their body weight in the first 3 months, which translates to approximately 15 to 20 pounds for someone starting at 230 pounds. Patients on the higher dose tracks tend to lose slightly more during this period.

Does weight loss slow down after month 6 on Mounjaro?

The rate of loss does decrease after month 6, which is a normal physiological response. However, weight continues to decrease through at least 18 months of treatment. Think of it as a gradual transition from active weight loss to weight stabilization at a much lower level.

Is losing 5 pounds per month on Mounjaro a good result?

Five pounds per month is an excellent rate of weight loss that is sustainable and healthy. Over 12 months, that pace would total 60 pounds, which exceeds the clinical trial average. Not every month will produce exactly 5 pounds, but averaging near that rate indicates strong response to treatment.

Why did I lose more weight in month 2 than month 5?

This pattern is common and normal. Early weight loss includes some water weight and initial metabolic response, which can produce higher numbers in the first few months. As your body adjusts to a lower weight, the monthly rate naturally moderates. The overall trajectory is what matters most.

Get Expert Monthly Monitoring with Form Blends

Form Blends provides physician-supervised Mounjaro and tirzepatide treatment with monthly progress reviews. Our telehealth platform lets you connect with your care team, review your monthly weight loss trajectory, and make data-driven adjustments to your treatment plan. get started with Form Blends

Start your consultation today and begin your Mounjaro journey with clinical guidance every step of the way.

Related Articles